Medicare Will Cover Flu Antivirals Under CMS Demonstration Project
This article was originally published in The Pink Sheet Daily
Executive Summary
The demo will allow CMS to collect data on how drug coverage affects beneficiaries’ health and costs ahead of the Medicare prescription drug benefit in 2006. Bristol’s Symmetrel, Forest’s Flumadine, Gilead’s Tamiflu and GlaxoSmithKline’s Relenza will be covered.